MiroBio has raised £27 million ($33 million) to fund research into immune cell regulation. The series A round will bankroll efforts to develop antibodies that treat autoimmune diseases by stimulating specific immune cell signals. Simon Davis and Richard Cornall, both of the University of Oxford, founded MiroBio to build on their research into immune-signaling mechanisms. Source: Fierce Biotech 7/10/2019